1. Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes. (20th February 2021) Authors: Yan, Xuefen; Wang, Lu; Jiang, Lingxu; Luo, Yingwan; Lin, Peipei; Yang, Wenli; Ren, Yanling; Ma, Liya; Zhou, Xinping; Mei, Chen; Ye, Li; Xu, Gaixiang; Xu, Weilai; Yang, Haiyang; Lu, Chenxi; Jin, Jie; Tong, Hongyan Journal: Cancer medicine Issue: Volume 10:Number 5(2021) Page Start: 1759 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Co‐mutation landscape and clinical significance of RAS pathway related gene mutations in patients with myelodysplastic syndrome. Issue 1 (9th November 2022) Authors: Ren, Yanling; Lang, Wei; Mei, Chen; Luo, Yingwan; Ye, Li; Wang, Lu; Zhou, Xinping; Xu, Gaixiang; Ma, Liya; Jin, Jie; Tong, Hongyan Journal: Hematological oncology Issue: Volume 41:Issue 1(2023) Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Empirical polymyxin B therapy in febrile neutropenic patients with hematological diseases: A prospective, multicenter, observational clinical study. Issue 4 (April 2023) Authors: Ma, Liya; Shen, Jianping; Jiang, Huifang; Qian, Shenxian; Zhang, Jin; Lan, Jianping; Zhou, Hua; Lang, Wei; Mei, Chen; Zhou, Xinping; Zhu, Lixia; Xu, Gaixiang; Ye, Li; Hu, Chao; Ren, Yanling; Yang, Xiudi; Jin, Jie; Ye, Xiujin; Tong, Hongyan Journal: Journal of infection Issue: Volume 86:Issue 4(2023) Page Start: 406 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Real‐world data of chronic myelomonocytic leukemia: A chinese single‐center retrospective study. (8th February 2021) Authors: Ma, Liya; Jiang, Lingxu; Yang, Wenli; Luo, Yingwan; Mei, Chen; Zhou, Xinping; Xu, Gaixiang; Xu, Weilai; Ye, Li; Ren, Yanlin; Lu, Chenxi; Lin, Peipei; Jin, Jie; Tong, Hongyan Journal: Cancer medicine Issue: Volume 10:Number 5(2021) Page Start: 1715 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial. Issue 6 (June 2022) Authors: Wang, Huafeng; Mao, Liping; Yang, Min; Qian, Pengxu; Lu, Huan; Tong, Hongyan; Xie, Wanzhuo; Zhou, De; Huang, Xin; Wang, Yungui; Xu, Gaixiang; Lu, Ying; Wei, Juying; Mai, Wenyuan; Ye, Xiujin; Meng, Haitao; Shen, Yaojia; Huang, Jian; Yu, Wenjuan; Sun, Jie Journal: Lancet Issue: Volume 9:Issue 6(2022) Page Start: e415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗